Based on the above discussed, patients with liver disease and DM may be benefited with incretin-based therapies due to their low liver toxicity and wide tolerance
Indeed, GCG antagonists, developed as potential glucose-lowering therapies, were associated with an increase in hepatic steatosis [38], suggesting that GCG agonists may reduce hepatic steatosis [39]
Patients can opt to purchase Zepbound directly from Eli Lilly, Kalayjian noted, but the medication is expensive, costing roughly $300-$500 per month
Treatment of Hypopigmentary Dermatoses Topical Pigment-inducing Therapy for Albinism Patients with albinism suffer from defects in key enzymes for melanin synthesis, resulting in a lack of melanin protection in the skin
Diabetes 60 , 19811989 (2011)